Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001890398 | SCV002156836 | likely benign | Noonan syndrome 9 | 2024-01-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004041269 | SCV005025046 | uncertain significance | Cardiovascular phenotype | 2024-09-02 | criteria provided, single submitter | clinical testing | The c.2275A>G (p.I759V) alteration is located in exon 14 (coding exon 14) of the SOS2 gene. This alteration results from a A to G substitution at nucleotide position 2275, causing the isoleucine (I) at amino acid position 759 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |